Effect of microalbuminuria lowering on regression of left ventricular hypertrophy in children and adolescents with essential hypertension

Pediatric Cardiology

Volumn 28, Issue 1, 2007, Pages 27-33

  Assadi, Farahnak ^a,b  

^a Rush Children's Hospital and Rush University Medical Center   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Hypertension; Left ventricular hypertrophy; Microalbuminuria

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; HYDROCHLOROTHIAZIDE; LOSARTAN;

ADOLESCENT; ADULT; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; BODY MASS; BODY SURFACE; BODY WEIGHT; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; ECHOCARDIOGRAPHY; ESSENTIAL HYPERTENSION; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE HYPERTROPHY; HEART VENTRICLE SIZE; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MICROALBUMINURIA; SCHOOL CHILD; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE;

ADOLESCENT; ADULT; AGE FACTORS; ALBUMINURIA; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CHILD; DISEASE PROGRESSION; FEMALE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 33847241901     PISSN: 01720643     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00246-006-1390-4     Document Type: Article

References (40)

1. Agrawal B, Berger A, Wolf K, Luft FC (1996) Microalbuminuria screening by reagent strip predicts cardiovascular risk in hypertension. J Hypertens 14:223-228
2. Assadi F (2002) Quantitation of microalbuminuria using random urine samples. Pediatr Nephrol 17:107-110
3. Asselbergs FW, Diercks FH, Hillege HL, et al. (2004) Effects of fosinopril and pravastatin on cardiovascular events in microalbuminuric subjects: results of the PREVEND IT. Circulation 10:2809-2816
4. Brenner BM, Cooper M, de Zeeuw D, et al. RENAAL Study Investigators (2001) Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 345:861-869
5. Briars GL, Bailey BG (1994) Surface area estimation: pocket calculator versus nomogram. Arch Dis Child 70:246-247
6. Daniels SR, Kimball TR, Morrison JA, Khoury P, Meyer RA (1995) Indexing left ventricular mass to account for differences in body size in children and adolescents without cardiac disease. Am J Cardiol 76:699-701
7. Dell'Omo G, Penno G, Giorgi D, et al. (2002) Association between high-normal albuminuria and risk factors for cardiovascular and renal disease in essential hypertensive men. Am J Kidney Dis 40:1-8
8. De Simone G, Daniels SR, Devereux RB, et al. (1992) Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight. J Am Coll Cardiol 20:1251-1260
9. De Simone G, Devereux RB, Daniels SR, et al. (1995) Effect of growth on variability of left ventricular mass: assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk. J Am Coll Cardiol 25:1056-1062
10. Devereux RB, Alonso DR, Lutas EM, et al. (1986) Echocardiograph assessment of left ventricular hypertrophy: comparison to necroscopy findings. Am J Cardiol 75:450-458
11. De Zeeuw (2004) Albuminuria, not only a cardiovascular/renal risk marker, but also a target for treatment? Kidney Int 66(Suppl 92):S2-S6
12. Festa A, D'Agostino O, Howard G, et al. (2000) Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects; the Insulin Resistance Atherosclerosis Study. Kidney Int 58:1703-1710
13. Gansevoort RT, de Zeeuw D, de Jong PE (1994) Is the antiproteinuric effect of ACE inhibition mediated by interference in the rennin-angiotensin system? Kidney Int 45:861-867
14. Grandi AM, Santillo R, Bertolini A, et al. (2001) Microalbuminuria as a marker of preclinical diastolic dysfunction in never treated essential hypertensives. Am J Hypertens 14:644-648
15. Herbert LA, Wilmer WA, Falkenhain ME, et al. (2001) Renoprotecion: one or many therapies? Kidney Int 59:1211-1226
16. Hillege HL, Fidler V, Diercks GF, et al. PREVEND Study Group (2002) Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation 106:1777-1782
17. Ibsen H, Olsen MH, Wachtell K, et al. (2005) Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients: Losartan Intervention for Endpoint Reduction in Hypertension Study. Hypertension 45:198-202
18. Jafar TH, Stark PC, Schmid CH, et al. AIPRD Study Group (2003) Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin converting enzyme inhibition. Ann Int Med 139:244-255
19. Jager A, Kostense PJ, Ruhe HG, et al. (1999) Microalbuminuria and peripheral arterial disease are independent predictors of cardiovascular and all-cause mortality, especially among hypertensive subjects; five-year follow-up of the Hoorn Study. Arterioscler Thromb Vase Biol 19:617-624
20. Jensen JS, Feldt-Rasmussen BO, Strandgaard S, Schroll M, Borch-Johnson K (2000) Arterial hypertension, microalbuminuria, and risk of ischemic heart disease. Hypertension 35:898-903
21. Julius S, Nesbitt SD, Egan BM, et al. (2006) Feasibility of treating prehypertension with an angiotensin-receptor blocker. N Engl J Med (in press, Epub ahead of print)
22. Knight EL, Kramer HM, Curhan GC (2003) High-normal blood pressure and microalbuminuria. Am J Kidney Dis 41:588-595
23. Kotchen TA, Piering AW, et al. (2000) Glomerular filtration in hypertensive African Americans. Hypertension 35:822-826
24. Mattman A, Eintracht S, Mock T, et al. (2006) Estimating pediatric glomerular filtration rates in the era of chronic kidney disease staging. J Am Soc Nephrol 17:485-496
25. Nathan DM, Rosenbaum C, Protasowski VD (1987) Single-voided samples can be used to estimate quantitative proteinuria. Diabetes Care 10:414-418
26. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children, Adolescents (2004). The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 114:555-576
27. Ogden CL, Kuczmarski RJ, Flegal KM, et al. (2002) Centers for Disease Control and Prevention 2000 growth charts for the United States: improvements to the 1977 National Center for Health Statistics version. Pediatrics 109:45-60
28. Pedrinelli R, Dell'Omo G, Di Bello V, Pontremoli R, Mariani M (2002) Microalbuminuria, an integrated marker of cardiovascular risk in essential hypertension. J Hum Hypertens 16:79-89
29. Pendrinelli R, Giampietro O, Carmassi F, et al. (1994) Microalbuminuria and endothelial dysfunction in essential hypertension. Lancet 344:14-18
30. Pontremoli R, Ravera M, Viazzi F, et al. (2000) Genetic polymorphism of the rennin-angiotensin system and organ damage in essential hypertension. Kidney 57:561-569
31. Reddan D, Owen W (2001) IgA nephropathy and inhibitors of the renin-angiotensin system: is reduction in proteinuria adequate proof of efficacy? Am J Kidney Dis 28:182-185
32. Rodicio J, Campo C, Ruilope L (1998) Microalbuminuria in essential hypertension. Kidney Int 54:551-554
33. Schwartz GJ, Haycock GB, Edelmann CM Jr, Spitzer A (1976) Predicting glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 106:522-526
34. The ACE Inhibitors in Diabetic Nephropathy Trialist Group (2001) Should all patients with type 1 diabetes mellitus and microalbuminuria receive angiotensin-converting enzyme inhibitors? Ann Intern Med 34:370-379
35. Vasan RS, Larson MG, Leio EP, et al. (2001) Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl Med 45:1291-1297
36. Viberti G, Wheeldon NM (2002) Microalbuminuria reduction with valsartan in patients with type 2 diabetes mellitus. A blood pressure independent effect. Circulation 106:672-678
37. Virdis A, Schiffrin EL (2003) Vascular inflammation: a role in vascular disease in hypertension? Curr Opin Nephrol Hygertens 12:181-187
38. Wachtell K, Palmieri V, Olson MH, et al. (2002) Urine albumin/creatinine ratio and electrocardiographic left ventricular structure and function in hypertensive patients with electrocardiographic left ventricular hypertrophy: The LIFE study. Losartan Intervention for Endpoint Reduction. Am Heart J 143:319-326
39. Wang TJ, Evans JC, Meigs JB, et al. (2005) Low-grade albuminuria and risks of hypertension and high blood pressure. Circulation 111:l370-1376
40. Wolf G, Ritz E (2005) Combination therapy with ACE inhibitors and angiotensin-receptor blockers to halt progression of chronic renal disease: pathophysiology and indications. Kidney Int 67:799-812